177 related articles for article (PubMed ID: 37794509)
1. The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition.
Zhou L; Wu J; Ruan M; Xiao Y; Lan H; Wu Q; Yu CW; Zhang Q
Breast Cancer Res; 2023 Oct; 25(1):115. PubMed ID: 37794509
[TBL] [Abstract][Full Text] [Related]
2. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
[TBL] [Abstract][Full Text] [Related]
3. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
[TBL] [Abstract][Full Text] [Related]
4. B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.
Li M; Che N; Feng Y; Liu X; Piao L; Xuan Y; Jin Y
Exp Mol Pathol; 2022 Apr; 125():104755. PubMed ID: 35278461
[TBL] [Abstract][Full Text] [Related]
5. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
Yan X; Hong B; Feng J; Jin Y; Chen M; Li F; Qian Y
BMC Cancer; 2022 Oct; 22(1):1053. PubMed ID: 36217128
[TBL] [Abstract][Full Text] [Related]
6. B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells.
Yin Y; Shi L; Yang J; Wang H; Yang H; Wang Q
Bioengineered; 2022 Jan; 13(1):107-118. PubMed ID: 34818980
[TBL] [Abstract][Full Text] [Related]
7. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Kim NI; Park MH; Kweon SS; Lee JS
Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
[TBL] [Abstract][Full Text] [Related]
8. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
[TBL] [Abstract][Full Text] [Related]
9. B7-Homolog 4 Promotes Epithelial-Mesenchymal Transition and Invasion of Bladder Cancer Cells via Activation of Nuclear Factor-κB.
Wu H; Wang X; Mo N; Zhang L; Yuan X; Lü Z
Oncol Res; 2018 Sep; 26(8):1267-1274. PubMed ID: 29391086
[TBL] [Abstract][Full Text] [Related]
10. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
El Din GS; Youness RA; Assal RA; Gad MZ
Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
[TBL] [Abstract][Full Text] [Related]
11. Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway.
Yu L; Ji Kim H; Kim B; Jung Byun H; Minh Nguyen T; Ji Kim E; Huy Phùng H; Hyeon Kim Y; Rahman M; Yun Jang J; Bae Rho S; Jin Kang G; Lee H; Lee K; Kyung Han H; Kyung Park M; Hoon Lee C
Biochem Pharmacol; 2023 Jun; 212():115537. PubMed ID: 37019184
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
13. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.
Zhang L; Wu H; Lu D; Li G; Sun C; Song H; Li J; Zhai T; Huang L; Hou C; Wang W; Zhou B; Chen S; Lu B; Zhang X
Oncogene; 2013 Nov; 32(46):5347-58. PubMed ID: 23318460
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
16. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
Leung J; Suh WK
J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
[TBL] [Abstract][Full Text] [Related]
17. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population.
Zhang J; Zhang M; Jiang W; Wang L; Fu Z; Li D; Pang D; Li D
BMC Cancer; 2009 Nov; 9():394. PubMed ID: 19903360
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L
Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer.
Wang L; Yang C; Liu XB; Wang L; Kang FB
Cancer Cell Int; 2018; 18():100. PubMed ID: 30008617
[TBL] [Abstract][Full Text] [Related]
20. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
